Natco Pharma Limited CC-Dec24.pdf
13 Feb 2025
-
Yes, good morning. Thanks for the opportunity.
Read in transcript -
Sequential earning of segment-wise revenue in export of formulation products. Basic reason I wanted to know that it has fallen below 25% if you take Q2 to Q3 of 2025. So, reason for this sudden fall, please enlighten us, sir? Thank you.
Read in transcript -
No, it is very significant on our earnings also. That is what. Is it the only reason or any other?
Read in transcript